Hongyang Duan; Da Xu; Yujie Gu; Ruihuan Wang; Guilian Li; Haican Liu; Machao Li; Xiuqin Zhao; Kanglin Wan; Hongyang Duan; Da Xu; Yujie Gu; Ruihuan Wang; Guilian Li; Haican Liu; Machao Li; Xiuqin Zhao; Kanglin Wan

doi:10.46234/ccdcw2025.142

[1]

Bouzeyen R, Javid B. Therapeutic vaccines for tuberculosis: an overview. Front Immunol 2022;13:878471. https://doi.org/10.3389/fimmu.2022.878471.

[2]

Jeyanathan M, Yao YS, Afkhami S, Smaill F, Xing Z. New tuberculosis vaccine strategies: taking aim at un-natural immunity. Trends Immunol 2018;39(5):419 − 33. https://doi.org/10.1016/j.it.2018.01.006.

[3]

Schrager LK, Vekemens J, Drager N, Lewinsohn DM, Olesen OF. The status of tuberculosis vaccine development. Lancet Infect Dis 2020;20(3):e28 − 37. https://doi.org/10.1016/S1473-3099(19)30625-5.

[4]

Omar S, Whitfield MG, Nolan MB, Ngom JT, Ismail N, Warren RM, et al. Bedaquiline for treatment of non-tuberculous mycobacteria (NTM): a systematic review and meta-analysis. J Antimicrob Chemother 2024;79(2):211 − 40. https://doi.org/10.1093/jac/dkad372.

[5]

Cao J, Lu JB, Xie AP, Xu M, Wang GZ, Shen XB, et al. Cross immune reaction between Mycobacteria smegmatis and Mycobacteria tuberculosis. Chin J Microbiol Immunol 2017;37(4):275 − 80. https://doi.org/10.3760/cma.j.issn.0254-5101.2017.04.007.

[6]

Wang XY, Li MC, Fan XT, Liu HC, Nan XT, Zhao XQ, et al. Study of gene homologous antigen, B cell antigen epitope and cross reaction with antibody IgG between two common non-tuberculous Mycobacteria and Mycobacterium tuberculosis. Disease Surv 2023;38(3):358 − 62. https://doi.org/10.3784/jbjc.202301030560.

[7]

Xiao SQ, Xu D, Duan HY, Fan XT, Li GL, Zhang W, et al. Immunogenicity of whole Mycobacterium intracellulare proteins and fingding on the cross-reactive proteins between M. intracellulare and M. tuberculosis. Biomed Environ Sci 2021;34(7):528 − 39. https://doi.org/10.3967/bes2021.073.

[8]

Deng JY, Bi LJ, Zhou L, Guo SJ, Fleming J, Jiang HW, et al. Mycobacterium tuberculosis proteome microarray for global studies of protein function and immunogenicity. Cell Rep 2014;9(6):2317 − 29. https://doi.org/10.1016/j.celrep.2014.11.023.

[9]

Xu Y, Liu W, Shen HB, Yan JR, Qu D, Wang HH. Recombinant Mycobacterium bovis BCG expressing the chimeric protein of antigen 85B and ESAT-6 enhances the Th1 cell-mediated response. Clin Vaccine Immunol 2009;16(8):1121 − 6. https://doi.org/10.1128/CVI.00112-09.

[10]

Baldwin SL, Reese VA, Larsen SE, Beebe E, Guderian J, Orr MT, et al. Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model. PLoS One 2021;16(3):e0247990. https://doi.org/10.1371/journal.pone.0247990.